COSderma China Laboratory (Wuhan, China)
Wuhan, Hubei, 430071, China
NCT Number: NCT07640321
Evaluate and compare the effects on female facial skin of oral placebo (Product A), N-acetylneuraminic acid (Product B), and ACAI-PLUS (Product C) after 28, 56, and 84 days under normal usage conditions.
Looking for future studies?
Notify Me40 year–65 year
Female
Observational
Wuhan, Hubei, 430071, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
≤ 6 according 10 points scale
Exclusion criteria
The non-inclusion general criteria were the following ones:
The non-inclusion specific criteria were the following ones:
Oral placebo once daily for 84 consecutive days
Oral N-acetylneuraminic acid, once daily, for 84 consecutive days
Oral ACAI-PLUS, once a day, for 84 consecutive days
Time frame: Day0、Day28、Day56、Day84
Dermatologists use a 10-point scale (0-9) and Volume 2 of the Atlas of Skin Aging for visual/tactile assessment. (includes elasticity, firmness, crow's feet, under-eye wrinkles, facial sagging, skin tone radiance, moisturization)
Time frame: Day0、Day28、Day56、Day84
Subjects self-rated using a 10-point scale (0-9). (includes skin beauty, visibility of wrinkles, skin tone evenness, radiance, firmness)
Time frame: Day0、Day28、Day56、Day84
Using Dermcup® high-frequency B-mode ultrasound scanning (25 MHz probe) to obtain dermal echo parameters
Time frame: Day0、Day28、Day56、Day84
Dermatologists use Pantone color cards to score the color and clarity of spots
Time frame: Day0、Day28、Day56、Day84
COSderma Photobench photography + Newtone software analysis to obtain information on wrinkles, skin tone uniformity, and spots
Time frame: Day0、Day28、Day56、Day84
Corneometer® CM825 capacitance measurement method to obtain Stratum corneum moisture index
Time frame: Day0、Day28、Day56、Day84
DTM310 Diastron® torque meter obtains information on skin biomechanical properties
Time frame: Day0、Day28、Day56、Day84
Siascope V® spectrophotometric intradermal analysis obtains information on freckle removal effects
Time frame: Day28、Day56、Day84
By distributing 12 questionnaires to the subjects, self-assessment information on the quality and effectiveness of cosmetics was obtained. A four-point Likert scale was used (Agree, Somewhat Agree, Somewhat Disagree, Disagree), and the questionnaire content included: 1. Skin feels better; 2. Skin becomes fairer; 3. Pigmentation on the skin lightens or decreases; 4. Skin becomes radiant; 5. Skin becomes more elastic; 6. Skin is firmer than before; 7. Skin wrinkles and fine lines improve; 8. Skin becomes moisturized/hydrated; 9. Skin's oil-water balance is better; 10. Skin looks rejuvenated, full of energy; 11. Sleep improves after consumption; 12. Memory improves after consumption.
Wuhan CASOV Green Biotech Co., Ltd
Other
Assessment and Comparison on 3 Groups of 25 Human Beings of the Effect on the Cutaneous State, the Dermis Echogenicity, the Moisturizing Effect, the Depigmenting Effect, the Effect on the Biomechanical Properties and the Effect on Wrinkles, Color and Homogeneity and Pigmentary Spots of Cosmetic Product N°1 vs Cosmetic Product N°2 vs Placebo After Oral Intake in Conditions of Normal Use During 28, 56 and 84 Days: Self-assessment of the Cosmetic Qualities and Efficacy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05760001
Behavior, Behavioral Symptoms
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT06690554
Behavior, Disorders of Environmental Origin
Konya, Turkey (Türkiye)
View Trial DetailsNCT07566143
Adherence Interventions, Aging
Van, Turkey (Türkiye)
View Trial DetailsNCT06835920
Behavior, Health Behavior
Chapel Hill, North Carolina, United States
View Trial Details